UNLIMITED TURBO LONG - QUEST DIAGNOSTICS | Market Closed - Boerse Frankfurt Warrants 01:20:30 25/05/2024 am IST | ||
| 2.78 EUR | +1.83% |
|
| Current month | +5.26% | ||
| 1 month | +8.95% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 2.8 | +2.56% |
| 23/24/23 | 2.73 | -3.53% |
| 22/24/22 | 2.83 | -5.67% |
| 21/24/21 | 3 | -2.28% |
| 20/24/20 | 3.07 | +0.99% |
Real-time Boerse Frankfurt Warrants
Last update May 25, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | 
BNP Paribas
|
| WKN | PZ0ZFN |
| ISIN | DE000PZ0ZFN0 |
| Date issued | 03/11/2023 |
| Strike | 114.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.18 € |
|---|---|
| Lowest since issue | 1.28 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.3
USD
Average target price
146.8
USD
Spread / Average Target
+3.91%
- Stock Market
- Certificates
- Certificat
